Regional Network for Mental Health Research in Latin America

描述（由申请人提供）：我们拉丁美洲中心（HLA）的首要目标是改善拉丁美洲严重精神障碍患者的状况。我们建议通过集中力量缩小“心理健康差距”来实现这一目标。我们的长期目标是改善为严重精神障碍患者提供的保健服务，直到这些服务相当于为高度重视一般健康状况的人提供的最佳保健服务。我们设想一个初级保健和二级精神卫生服务的综合系统，我们称之为严重精神障碍患者的社区卫生保健（CHC-SMD）。我们采取多管齐下的方法，适合拉丁美洲城市地区的独特背景。我们在5年资助期内的目标是启动战略举措，在该地区实现CHC-SMD取得重大进展，并为长期持续进展建立平台。 HLA汇集了来自拉丁美洲六个城市（智利圣地亚哥;巴西里约热内卢;布宜诺斯艾利斯，科尔多瓦，内乌肯，阿根廷;哥伦比亚麦德林）的主要研究人员和利益相关者与纽约市的研究人员共同努力，朝着CHC-SMD的共同愿景取得进展。这些组成部分被设计成协同作用，使整个HLA的影响大于其部分的总和。例如，研究部分提议进行一项区域随机对照试验（RCT）。为了使HLA按计划进行全面的区域随机对照试验，能力建设部分将需要培训HLA研究中心的领导人，以开展随机对照试验并协调区域研究。与此同时，试验性随机对照试验将通过提供随机对照试验和区域研究方面的实际经验，帮助建立这种能力。 我们的总体具体目标是：（a）部署和评估能够加快CHC-SMD进展的任务转移方法;（B）培训年轻领导人，使其具备实现CHC-SMD持续进展所需的能力;（c）汇集多个利益攸关方，为实施和塑造CHC-SMD做出贡献。

DESCRIPTION (provided by applicant): The overriding objective of our Hub for Latin America (HLA) is to improve the condition of people with severe mental disorders in Latin America. We propose to do so by making a focused contribution to narrowing the "mental health gap". Our long-term goal is to improve health services for people with severe mental disorders until they are equivalent to the best health services offered to people with highly prioritized general health conditions. We envision an integrated system of primary care and secondary mental health services that we refer to as Community Health Care for individuals with Severe Mental Disorders (CHC-SMD). We adopt a multi-pronged approach that is tailored to the distinctive context of the urban areas of Latin America. Our goals for the 5-year grant period are to launch strategic initiatives that will generate significant progress toward CHC-SMD in this region, and to build a platform for ongoing progress over a longer time period. The HLA brings together key researchers and stakeholders from six cities across Latin America (Santiago, Chile; Rio de Janeiro, Brazil; Buenos Aires, Cordoba, Neuquen, Argentina; Medellin, Colombia) with researchers in New York City in a concerted effort to make progress toward a shared vision of CHC-SMD. The Components are designed to be synergistic so that the impact of the whole HLA is greater than the sum of its parts. The Research Component, for example, proposes to pilot a regional randomized controlled trial (RCT). In order for the HLA to proceed as planned to conduct a full scale regional RCT, the Capacity Building Component will need to train leaders at the HLA sites to conduct RCTs and coordinate regional studies. At the same time, the pilot RCT will help generate this capacity by providing practical experience in RCTs and regional studies. Our overall specific aims are (a) to deploy and evaluate task shifting approaches that can accelerate progress toward CHC-SMD; (b) to train young leaders with the capacities required to generate ongoing progress toward CHC-SMD; and (c) to bring together multiple stakeholders to contribute to implementing and shaping CHC-SMD.